Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2024 Feb 9;17(2):230. doi: 10.3390/ph17020230

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2024 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

SAMA activates caspases 8 and 9 in oral cancer cells. (A,C) Caspase 8 and 9 activation assays of SAMA. Cells were treated with 0.1% DMSO (untreated control) and SAMA (0, 15, and 25 μg/mL) for 24 h. (+) is assigned to the caspase 8 and 9 (+) (%) region. (B,D) Caspase 8 and 9 assays with NAC/SAMA. NAC/SAMA represents the pre-treatment of 10 mM NAC for 1 h and the post-treatment of 25 μg/mL SAMA for 0, 12, and 24 h. Data are shown as means ± SD (triplicate). An absence of overlapping annotations (lowercase notes) between treatments indicated a significant difference (p < 0.05).

SAMA activates caspases 8 and 9 in oral cancer cells. (A,C) Caspase 8 and 9 activation assays of SAMA. Cells were treated with 0.1% DMSO (untreated control) and SAMA (0, 15, and 25 μg/mL) for 24 h. (+) is assigned to the caspase 8 and 9 (+) (%) region. (B,D) Caspase 8 and 9 assays with NAC/SAMA. NAC/SAMA represents the pre-treatment of 10 mM NAC for 1 h and the post-treatment of 25 μg/mL SAMA for 0, 12, and 24 h. Data are shown as means ± SD (triplicate). An absence of overlapping annotations (lowercase notes) between treatments indicated a significant difference (p < 0.05).